Hundreds will benefit after the first targeted treatment for the most common form of bladder cancer was given the green light ...

A new systematic review explores how prehabilitation—through exercise, education, nutrition, and lifestyle changes—affects ...

The first targeted treatment for the most common form of bladder cancer has been given the green light for NHS use. The ...

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

Hundreds will benefit after the first targeted treatment for the most common form of bladder cancer was given the green light ...

The drug, recommended by NICE, works by blocking certain proteins to slow down or stop the growth of cancer cells ...

Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

A groundbreaking targeted treatment for the most common type of bladder cancer has been approved for use by the NHS, offering new hope to hundreds of patients. The National Institute of Health and ...

The investigational therapy combines mRNA technology with immunotherapy to train the immune system to target cancer cells ...